Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Pawana, Pusuwan"'
Publikováno v:
Siriraj Medical Journal, Vol 64, Iss 4 (2020)
Objective: The purpose of this study was to evaluate the success rate in preparation of patients with thyroid cancer for I-131 total body scan by 3-week discontinuation of LT4 including clinical characteristics affecting the success. Methods: Nine
Externí odkaz:
https://doaj.org/article/c8b975d486264e4b8671270b823d61c2
Publikováno v:
Siriraj Medical Journal, Vol 62, Iss 2 (2020)
Objective: To study the ability of somatostatin receptor scintigraphy using Tc-99m-hydrazinonicotinyl-Tyr3-octreotide (Tc-99m-HYNIC-TOC) for localization of pancreatic neuroendocrine tumors. Methods: Five patients (3 female, 2 male; age range: 53
Externí odkaz:
https://doaj.org/article/db5bd1b9604842818a59173e36c84185
Publikováno v:
Siriraj Medical Journal, Vol 70, Iss 2, Pp 169-174 (2018)
Objective: To determine the impact of Fluorine-18 fluorodeoxy glucose (18F-FDG) positron emission tomography with computed tomography (PET/CT scan) on management of non-small cell lung cancer (NSCLC) in contexts of university-based hospital in Thai
Externí odkaz:
https://doaj.org/article/c656015f75f048fd9e84a70f9b95157d
Autor:
Achiraya Teyateeti, M.D., Titiporn Jiranantanakorn, M.D., Ajalaya Teyateeti, M.D., Pawana Pusuwan, M.D.
Publikováno v:
Siriraj Medical Journal, Vol 70, Iss 1, Pp 77-80 (2018)
Objective: To present an uncommon presentation of metastatic non-small cell lung cancer at mandible causing numb chin syndrome (NCS), diagnosed by PET/CT scan. Case presentation: A 72-year-old man presented with decreased sensation of left lower li
Externí odkaz:
https://doaj.org/article/7490010f68c34c2c8ac180485c1ee291
Publikováno v:
Siriraj Medical Journal, Vol 68, Iss 5, Pp 291-298 (2016)
Objective: To evaluate outcome of radioactive iodine (RAI) ablation/treatment in pathologically defined low risk of recurrence well-differentiated thyroid carcinoma (WDTC) patients. Methods: A 7-year retrospective review of medical records was done
Externí odkaz:
https://doaj.org/article/5c17b09140fc4c029d8d624045b1c922
Autor:
Ajalaya Teyateeti, Potjanee Kanchanapiboon, Chutina Vasansirikul, Chulaluk Komoltri, Pawana Pusuwan
Publikováno v:
Siriraj Medical Journal, Vol 68, Iss 4, Pp 229-234 (2016)
Objective: To evaluate success rate and factors affecting the success of radioactive iodine (RAI) ablation in low-risk of recurrence well-differentiated thyroid carcinoma patients. Methods: Retrospective review of medical records was done in 132 lo
Externí odkaz:
https://doaj.org/article/dd1755fd1fb9493592afe8fdfdfffba9
Publikováno v:
Siriraj Medical Journal, Vol 68, Iss 4, Pp 265-270 (2016)
A 72-year-old woman, known case of Graves’ disease with anti-thyroid drug hypersensitivity was sent for radioactive iodine ablation prior to surgical resection of an ovarian tumor. Her 24-hour radioactive iodine thyroid uptake was normal. Thus, r
Externí odkaz:
https://doaj.org/article/621a7ec393b5496a9b80fe502b8b42e2
Autor:
Kulachart Jangpatarapongsa, Eric C. Frey, Ajalaya Teyateeti, Anucha Chaichana, Pawana Pusuwan, Chiraporn Tocharoenchai, Kijja Rhoongsittichai
Publikováno v:
Medical Physics. 48:7877-7890
Purpose 90 Y selective internal radiation therapy (SIRT) has become a safe and effective treatment option for liver cancer. However, segmentation of target and organ-at-risks is labor-intensive and time-consuming in 90 Y SIRT planning. In this study,
Autor:
Pawana Pusuwan
Publikováno v:
Siriraj Medical Journal, Vol 68, Iss 5 (2016)
Objective: To evaluate outcome of radioactive iodine (RAI) ablation/treatment in pathologically defined low risk of recurrence well-differentiated thyroid carcinoma (WDCT) patients. Methods: A 7-year retrospective review of medical records was done i
Externí odkaz:
https://doaj.org/article/c2463cfd5e3144819b6a5e3c9b568774
Autor:
Pawana Pusuwan, Chalermrat Kaewput
Publikováno v:
World Journal of Nuclear Medicine, Vol 20, Iss 1, Pp 54-60 (2021)
World Journal of Nuclear Medicine
World Journal of Nuclear Medicine
To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review of medical records was done in 176 DTC patients with a cumu